FDA clears the way for additional bivalent boosters for certain vulnerable individuals

FDA clears the way for additional bivalent boosters for certain vulnerable individuals

The U.S. Food and Drug Administration amended the terms of its emergency use authorizations for the Pfizer and Moderna bivalent vaccines on Tuesday, allowing people ages 65 and older and certain people with weakened immunity to get additional doses before this fall’s vaccination campaigns.